Search
Menu
Home
HTB
2006
February
10
10 February 2006
Contents
Conference reports
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
Understanding TMC114 power against resistant HIV
New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
Predictors of insulin resistance in first year of therapy
Three measures confirm 144-week renal record of tenofovir
Low rash risk with efavirenz after nevirapine rash
HTB RSS
Early access
US government has altered more than 100 scientific databases since 20 January
5 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
Why the new HIV PrEP guidelines from the UK are so exciting (2025)
2 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate